Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-301
Closed -$13K 856
2022
Q3
$13K Sell
301
-73
-20% -$3.61K ﹤0.01% 496
2022
Q2
$19K Buy
374
+79
+27% +$3.85K ﹤0.01% 425
2022
Q1
$15K Buy
295
+48
+19% +$2.48K ﹤0.01% 462
2021
Q4
$15K Buy
247
+78
+46% +$4.47K ﹤0.01% 478
2021
Q3
$9K Hold
169
﹤0.01% 533
2021
Q2
$9K Sell
169
-21
-11% -$1.08K ﹤0.01% 515
2021
Q1
$10K Buy
190
+39
+26% +$2.14K ﹤0.01% 493
2020
Q4
$8K Buy
+151
New +$8.06K ﹤0.01% 521
2020
Q3
Sell
-145
Closed -$7K 858
2020
Q2
$7K Hold
145
﹤0.01% 489
2020
Q1
$6K Sell
145
-142
-49% -$5.55K ﹤0.01% 489
2019
Q4
$10K Buy
+287
New +$10.7K ﹤0.01% 475

Other funds holding QGEN

Howe & Rusling's QGEN Position: Q4 2022 in Review

Howe & Rusling sold out of Qiagen (QGEN) in Q4 2022, closing a stake of 301 shares — an estimated $13K sold.

Howe & Rusling first reported a position in QGEN in Q4 2019 and held it in 11 quarters. The position peaked at $19K in Q2 2022. 297 funds tracked by Wall St. Rank hold QGEN as of Q4 2022.

  • Howe & Rusling reported no remaining Qiagen position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 301 Qiagen shares in Q4 2022, an estimated $13K.
  • Howe & Rusling first reported a position in Qiagen in Q4 2019 and held it in 11 quarters.
  • Howe & Rusling's Qiagen position peaked at $19K in Q2 2022.
  • 297 funds tracked by Wall St. Rank held Qiagen as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.